The growth of tumors derived from TamR/anti-575 was inhibited by tamoxifen treatment (Figure 8F-G), suggesting that miR-575 depletion reverses tamoxifen resistance in ER+ breast cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.